Schedule of Investments
Emerald Growth Fund
January 31, 2026 (Unaudited)
| Shares | Value (Note 2) | |||||||
| COMMON STOCKS: 93.44% | ||||||||
| Consumer Discretionary: 7.35% | ||||||||
| 554,215 | Arhaus, Inc.(a) | $ | 5,641,909 | |||||
| 727,843 | Arlo Technologies, Inc.(a) | 9,236,328 | ||||||
| 199,537 | BJ's Restaurants, Inc.(a) | 8,344,637 | ||||||
| 78,417 | Boot Barn Holdings, Inc.(a) | 13,995,866 | ||||||
| 318,485 | IMAX Corp.(a) | 11,118,311 | ||||||
| 200,325 | Life Time Group Holdings, Inc.(a) | 5,843,480 | ||||||
| 577,474 | National Vision Holdings, Inc.(a) | 15,216,440 | ||||||
| 387,670 | OneSpaWorld Holdings, Ltd. | 7,617,716 | ||||||
| 594,569 | Rush Street Interactive, Inc.(a) | 10,506,034 | ||||||
| 34,176 | Visteon Corp. | 3,105,232 | ||||||
| 90,625,953 | ||||||||
| Consumer Staples: 3.30% | ||||||||
| 28,000 | Five Below, Inc.(a) | 5,365,920 | ||||||
| 152,694 | Freshpet, Inc.(a) | 10,642,772 | ||||||
| 114,419 | Ollie's Bargain Outlet Holdings, Inc.(a) | 12,621,560 | ||||||
| 423,126 | Vital Farms, Inc.(a) | 12,037,934 | ||||||
| 40,668,186 | ||||||||
| Consumer, Cyclical: 0.70% | ||||||||
| 206,522 | Black Rock Coffee Bar, Inc.(a) | 3,079,243 | ||||||
| 345,294 | First Watch Restaurant Group, Inc.(a) | 5,521,251 | ||||||
| 8,600,494 | ||||||||
| Consumer, Non-cyclical: 3.35% | ||||||||
| 453,588 | Aveanna Healthcare Holdings, Inc.(a) | 3,810,139 | ||||||
| 28,125 | Axsome Therapeutics, Inc.(a) | 5,182,031 | ||||||
| 55,556 | Billiontoone, Inc.(a) | 4,583,926 | ||||||
| 99,801 | Corvus Pharmaceuticals, Inc.(a) | 2,065,881 | ||||||
| 428,847 | Invivyd, Inc.(a) | 746,194 | ||||||
| 336,137 | Lumexa Imaging Holdings, Inc.(a) | 4,117,678 | ||||||
| 105,243 | Mirum Pharmaceuticals, Inc.(a) | 10,863,182 | ||||||
| 104,721 | Nektar Therapeutics(a) | 3,909,235 | ||||||
| 579,245 | Trevi Therapeutics, Inc.(a) | 6,064,695 | ||||||
| 41,342,961 | ||||||||
| Energy: 2.47% | ||||||||
| 246,897 | American Superconductor Corp.(a) | 7,387,158 | ||||||
| 101,127 | Excelerate Energy, Inc. | 3,777,094 | ||||||
| 145,986 | Solaris Energy Infrastructure, Inc. | 8,056,967 | ||||||
| 979,680 | TETRA Technologies, Inc.(a) | 11,168,352 | ||||||
| 30,389,571 | ||||||||
| Financial Services: 13.55% | ||||||||
| 159,805 | American Integrity Insurance Group, Inc.(a) | 2,986,755 | ||||||
| 2,708 | Ategrity Specialty Holdings LLC(a) | 48,229 | ||||||
| Shares | Value (Note 2) | |||||||
| Financial Services (continued) | ||||||||
| 192,287 | Axos Financial, Inc.(a) | $ | 19,034,490 | |||||
| 179,566 | Bancorp, Inc.(a) | 10,673,403 | ||||||
| 79,142 | Coastal Financial Corp.(a) | 7,580,221 | ||||||
| 633,907 | Compass, Inc.(a) | 7,936,516 | ||||||
| 129,064 | Customers Bancorp, Inc.(a) | 10,198,637 | ||||||
| 13,531 | Enova International, Inc.(a) | 2,234,915 | ||||||
| 70,213 | GBank Financial Holdings, Inc.(a) | 2,284,029 | ||||||
| 353,912 | LendingClub Corp.(a) | 5,984,652 | ||||||
| 136,911 | LendingTree, Inc.(a) | 7,757,377 | ||||||
| 150,038 | Mid Penn Bancorp, Inc. | 4,949,754 | ||||||
| 218,768 | Moelis & Co., Class A | 15,679,103 | ||||||
| 41,232 | Neptune Insurance Holdings, Inc.(a) | 1,051,416 | ||||||
| 25,000 | Norwood Financial Corp. | 760,750 | ||||||
| 94,386 | Palomar Holdings, Inc.(a) | 11,665,166 | ||||||
| 365,213 | Perella Weinberg Partners | 8,147,902 | ||||||
| 29,650 | Piper Sandler Cos. | 10,269,278 | ||||||
| 161,030 | Seacoast Banking Corp. of Florida | 5,384,843 | ||||||
| 232,362 | Skyward Specialty Insurance Group, Inc.(a) | 10,367,992 | ||||||
| 284,689 | Slide Insurance Holdings, Inc.(a) | 4,905,191 | ||||||
| 338,791 | Trinity Capital, Inc. | 5,701,853 | ||||||
| 89,176 | UMB Financial Corp. | 11,337,837 | ||||||
| 166,940,309 | ||||||||
| Healthcare: 13.01% | ||||||||
| 192,168 | ACADIA Pharmaceuticals, Inc.(a) | 4,829,182 | ||||||
| 633,536 | Alphatec Holdings, Inc.(a) | 9,395,339 | ||||||
| 142,057 | Bridgebio Pharma, Inc.(a) | 10,976,744 | ||||||
| 382,344 | Cogent Biosciences, Inc.(a) | 13,729,973 | ||||||
| 187,077 | Collegium Pharmaceutical, Inc.(a) | 8,590,576 | ||||||
| 74,747 | Corcept Therapeutics, Inc.(a) | 2,980,163 | ||||||
| 267,813 | Guardant Health, Inc.(a) | 30,541,395 | ||||||
| 300,117 | KalVista Pharmaceuticals, Inc.(a) | 4,684,826 | ||||||
| 180,572 | LivaNova PLC(a) | 11,865,386 | ||||||
| 10,005 | Madrigal Pharmaceuticals, Inc.(a) | 4,895,547 | ||||||
| 21,567 | Merit Medical Systems, Inc.(a) | 1,748,868 | ||||||
| 141,804 | RadNet, Inc.(a) | 9,940,460 | ||||||
| 798,875 | Savara, Inc.(a) | 4,313,925 | ||||||
| 106,179 | Soleno Therapeutics, Inc.(a) | 4,094,262 | ||||||
| 153,485 | Spyre Therapeutics, Inc.(a) | 4,908,450 | ||||||
| 107,847 | TransMedics Group, Inc.(a) | 14,448,802 | ||||||
| 406,282 | Travere Therapeutics, Inc.(a) | 12,631,307 | ||||||
| 447,507 | WaVe Life Sciences, Ltd.(a) | 5,790,741 | ||||||
| 160,365,946 | ||||||||
| Industrials: 23.71% | ||||||||
| 153,709 | AAR Corp.(a) | 16,279,320 | ||||||
| 75,176 | AeroVironment, Inc.(a) | 20,928,247 | ||||||
| 127,486 | Allegiant Travel Co.(a) | 11,299,084 | ||||||
| 35,775 | Argan, Inc. | 12,417,860 | ||||||
| 113,839 | ATI, Inc.(a) | 13,694,832 | ||||||
| 216,236 | Bloom Energy Corp., Class A(a) | 32,731,643 | ||||||
| 64,347 | Bowman Consulting Group, Ltd.(a) | 2,241,206 | ||||||
| Shares | Value (Note 2) | |||||||
| Industrials (continued) | ||||||||
| 150,655 | Byrna Technologies, Inc.(a) | $ | 2,065,480 | |||||
| 179,041 | Cardinal Infrastructure Group, Inc.(a) | 4,510,043 | ||||||
| 23,823 | Carpenter Technology Corp. | 7,571,664 | ||||||
| 151,897 | CECO Environmental Corp.(a) | 10,242,415 | ||||||
| 1,488,032 | Evolv Technologies Holdings, Inc.(a) | 9,210,918 | ||||||
| 354,552 | First Advantage Corp.(a) | 4,786,452 | ||||||
| 305,429 | Kratos Defense & Security Solutions, Inc.(a) | 31,462,241 | ||||||
| 351,654 | Latham Group, Inc.(a) | 2,211,904 | ||||||
| 208,114 | Mercury Systems, Inc.(a) | 19,537,742 | ||||||
| 436,745 | Mirion Technologies, Inc.(a) | 10,848,746 | ||||||
| 143,133 | Modine Manufacturing Co.(a) | 26,430,940 | ||||||
| 13,932 | Plexus Corp.(a) | 2,777,066 | ||||||
| 102,158 | Shift4 Payments, Inc.(a) | 6,031,408 | ||||||
| 57,383 | SPX Technologies Inc(a) | 11,959,191 | ||||||
| 29,665 | Sterling Infrastructure, Inc.(a) | 10,617,400 | ||||||
| 102,180 | VSE Corp. | 22,333,483 | ||||||
| 292,189,285 | ||||||||
| Producer Durables: 1.91% | ||||||||
| 130,344 | Astronics Corp.(a) | 9,873,558 | ||||||
| 60,108 | ESCO Technologies, Inc. | 13,714,842 | ||||||
| 23,588,400 | ||||||||
| Technology: 22.64% | ||||||||
| 128,147 | Agilysys, Inc.(a) | 11,116,752 | ||||||
| 242,324 | Applied Optoelectronics, Inc.(a) | 10,567,749 | ||||||
| 72,793 | Commvault Systems, Inc.(a) | 6,238,360 | ||||||
| 175,631 | Credo Technology Group Holding, Ltd.(a) | 22,003,052 | ||||||
| 222,690 | D-Wave Quantum, Inc.(a) | 4,725,482 | ||||||
| 242,434 | EverQuote, Inc., Class A(a) | 5,503,252 | ||||||
| 39,675 | Fabrinet(a) | 19,418,532 | ||||||
| 79,900 | HeartFlow, Inc.(a) | 2,386,613 | ||||||
| 60,185 | Impinj, Inc.(a) | 8,311,548 | ||||||
| 21,435 | InterDigital, Inc. | 6,997,241 | ||||||
| 172,267 | IonQ, Inc.(a) | 6,887,235 | ||||||
| 101,429 | IPG Photonics Corp.(a) | 9,373,054 | ||||||
| 194,073 | Kulicke & Soffa Industries, Inc. | 11,126,205 | ||||||
| 247,331 | nLight, Inc.(a) | 11,280,767 | ||||||
| 46,457 | Onto Innovation, Inc.(a) | 9,386,637 | ||||||
| 350,922 | PDF Solutions, Inc.(a) | 11,176,866 | ||||||
| 183,378 | Q2 Holdings, Inc.(a) | 11,231,902 | ||||||
| 241,019 | Rambus, Inc.(a) | 27,435,193 | ||||||
| 173,131 | Semtech Corp.(a) | 13,807,197 | ||||||
| 31,790 | SiTime Corp.(a) | 11,543,267 | ||||||
| 167,424 | SkyWater Technology, Inc.(a) | 5,300,644 | ||||||
| 126,470 | Synaptics, Inc.(a) | 10,435,040 | ||||||
| 330,159 | TTM Technologies, Inc.(a) | 32,421,614 | ||||||
| 344,646 | Varonis Systems, Inc.(a) | 10,284,237 | ||||||
| 278,958,439 | ||||||||
| Shares | Value (Note 2) | |||||||
| Telecommunications: 1.45% | ||||||||
| 45,671 | Lumentum Holdings, Inc.(a) | $ | 17,895,725 | |||||
| Total Common Stocks | ||||||||
| (Cost $701,820,590) | 1,151,565,269 | |||||||
| MUTUAL FUND: 5.78% | ||||||||
| Healthcare: 5.78% | ||||||||
| 1,997,035 | F/m Emerald Life Sciences Innovation ETF(a)(b) | 71,174,327 | ||||||
| Total Mutual Fund | ||||||||
| (Cost $31,078,469) | 71,174,327 | |||||||
| SHORT TERM INVESTMENTS: 1.15% | ||||||||
| 14,144,446 | First American Government Obligations Fund, Class X 3.612% (c) | 14,144,446 | ||||||
| Total Short Term Investments | ||||||||
| (Cost $14,144,446) | 14,144,446 | |||||||
| Total Investments: 100.37% | ||||||||
| (Cost $747,043,505) | 1,236,884,042 | |||||||
| Liabilities In Excess Of Other Assets: (0.37)% | (4,544,455 | ) | ||||||
| Net Assets: 100.00% | $ | 1,232,339,587 | ||||||
| (a) | Non-income producing security. |
| (b) | Affiliated company. See Note 3 in Notes to Quarterly Schedule of Investments. |
| (c) | Represents the 7-day yield. |
For Fund compliance purposes, the Fund's industry classifications refer to any one or more of the industry sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by Fund management. This definition may not apply for purposes of this report, which may combine industry sub-classifications for reporting ease. Industries are shown as a percentage of net assets.
See Notes to Quarterly Schedule of Investments.
Schedule of Investments
Emerald Finance & Banking Innovation Fund
January 31, 2026 (Unaudited)
| Shares | Value (Note 2) | |||||||
| COMMON STOCKS: 97.90% | ||||||||
| Communications: 1.12% | ||||||||
| Internet: 1.12% | ||||||||
| 4,053 | Shopify, Inc., Class A(a) | $ | 531,875 | |||||
| Consumer, Non-cyclical: 1.65% | ||||||||
| Commercial Services: 1.65% | ||||||||
| 6,520 | Affirm Holdings, Inc.(a) | 393,156 | ||||||
| 17,146 | Klarna Group PLC(a) | 395,558 | ||||||
| 788,714 | ||||||||
| Financial Services: 82.29% | ||||||||
| Banks: 58.73% | ||||||||
| 4,442 | Ameris Bancorp | 358,114 | ||||||
| 26,010 | Axos Financial, Inc.(a) | 2,574,730 | ||||||
| 32,889 | Bancorp, Inc.(a) | 1,954,922 | ||||||
| 10,435 | Bank7 Corp. | 463,731 | ||||||
| 5,156 | CNB Financial Corp. | 142,821 | ||||||
| 20,589 | Coastal Financial Corp.(a) | 1,972,015 | ||||||
| 31,064 | Customers Bancorp, Inc.(a) | 2,454,677 | ||||||
| 6,314 | East West Bancorp, Inc. | 722,574 | ||||||
| 22,496 | Esquire Financial Holdings, Inc. | 2,398,749 | ||||||
| 54,364 | Finwise Bancorp(a) | 951,914 | ||||||
| 10,289 | Five Star Bancorp | 407,650 | ||||||
| 4,478 | GBank Financial Holdings, Inc.(a) | 145,669 | ||||||
| 60,462 | Mechanics Bancorp | 906,325 | ||||||
| 27,099 | Metropolitan Bank Holding Corp. | 2,509,367 | ||||||
| 27,293 | MVB Financial Corp. | 770,754 | ||||||
| 21,124 | Northeast Bancorp | 2,434,119 | ||||||
| 18,470 | Pathward Financial, Inc. | 1,667,656 | ||||||
| 3,676 | Private Bancorp of America, Inc.(a) | 220,560 | ||||||
| 13,110 | QCR Holdings, Inc. | 1,183,309 | ||||||
| 13,306 | Seacoast Banking Corp. of Florida | 444,953 | ||||||
| 19,108 | Third Coast Bancshares, Inc.(a) | 775,021 | ||||||
| 14,347 | Western Alliance Bancorp | 1,279,035 | ||||||
| 8,733 | Wintrust Financial Corp | 1,288,030 | ||||||
| 28,026,695 | ||||||||
| Banks: Diversified: 2.35% | ||||||||
| 7,000 | First Busey Corp. | 172,550 | ||||||
| 4,373 | Mid Penn Bancorp, Inc. | 144,265 | ||||||
| 4,256 | UMB Financial Corp. | 541,108 | ||||||
| 6,277 | United Bankshares, Inc. | 265,706 | ||||||
| 1,123,629 | ||||||||
| Computer Services: 0.18% | ||||||||
| 16,576 | Opendoor Technologies, Inc.(a) | 85,366 | ||||||
| Consumer Lending: 7.13% | ||||||||
| 6,371 | Enova International, Inc.(a) | 1,052,298 | ||||||
| Shares | Value (Note 2) | |||||||
| Consumer Lending (continued) | ||||||||
| 108,783 | LendingClub Corp.(a) | $ | 1,839,521 | |||||
| 22,392 | SoFi Technologies, Inc.(a) | 510,761 | ||||||
| 3,402,580 | ||||||||
| Diversified Finan Serv: 2.25% | ||||||||
| 11,558 | BitMine Immersion Technologies, Inc. | 290,106 | ||||||
| 2,282 | Circle Internet Group, Inc.(a) | 145,888 | ||||||
| 2,478 | Dave, Inc.(a) | 405,624 | ||||||
| 2,500 | Miami International Holdings, Inc.(a) | 104,325 | ||||||
| 5,763 | Perella Weinberg Partners | 128,572 | ||||||
| 1,074,515 | ||||||||
| Insurance: 5.35% | ||||||||
| 11,624 | American Integrity Insurance Group, Inc.(a) | 217,252 | ||||||
| 7,410 | Ategrity Specialty Holdings LLC(a) | 131,972 | ||||||
| 8,914 | Bowhead Specialty Holdings, Inc.(a) | 218,928 | ||||||
| 55,248 | Neptune Insurance Holdings, Inc.(a) | 1,408,824 | ||||||
| 10,211 | Skyward Specialty Insurance Group, Inc.(a) | 455,615 | ||||||
| 4,900 | TWFG, Inc.(a) | 122,451 | ||||||
| 2,555,042 | ||||||||
| Investment Services: 0.51% | ||||||||
| 1,251 | Coinbase Global, Inc., Class A(a) | 243,620 | ||||||
| Mortgage Finance: 2.03% | ||||||||
| 54,049 | Rocket Cos., Inc. | 969,099 | ||||||
| Open End And Misc Investment Vehicles: 1.09% | ||||||||
| 30,950 | Trinity Capital, Inc. | 520,889 | ||||||
| Property And Casualty Insurance: 2.06% | ||||||||
| 533 | Kinsale Capital Group, Inc. | 211,004 | ||||||
| 3,718 | Palomar Holdings, Inc.(a) | 459,508 | ||||||
| 39,577 | Porch Group, Inc.(a) | 312,262 | ||||||
| 982,774 | ||||||||
| Real Estate: 0.61% | ||||||||
| 23,156 | Compass, Inc.(a) | 289,913 | ||||||
| Industrials: 2.45% | ||||||||
| Transaction Processing Services: 2.45% | ||||||||
| 95,976 | Green Dot Corp., Class A(a) | 1,168,988 | ||||||
| Materials & Processing: 0.78% | ||||||||
| Aluminum: 0.78% | ||||||||
| 28,159 | Real Industry, Inc.(a) | 372,262 | ||||||
| Technology: 9.61% | ||||||||
| Computers: 3.32% | ||||||||
| 27,860 | Figure Technology Solutions, Inc.(a) | 1,584,677 | ||||||
| Internet: 3.23% | ||||||||
| 15,504 | Robinhood Markets, Inc.(a) | 1,542,338 | ||||||
| Shares | Value (Note 2) | |||||||
| Software: 3.06% | ||||||||
| 5,000 | Bullish(a) | $ | 151,000 | |||||
| 27,736 | Chime Financial, Inc.(a) | 705,049 | ||||||
| 31,165 | Pagaya Technologies, Ltd.(a) | 604,289 | ||||||
| 1,460,338 | ||||||||
| Total Common Stocks | ||||||||
| (Cost $33,408,433) | 46,723,314 | |||||||
| RIGHTS AND WARRANTS: 0.00% | ||||||||
| 552 | Opendoor Technologies, Inc., Strike Price $9.00, Expiration Date 11/20/2026 | 470 | ||||||
| 552 | Opendoor Technologies, Inc., Strike Price $13.00, Expiration Date 11/20/2026 | 251 | ||||||
| 552 | Opendoor Technologies, Inc., Strike Price $17.00, Expiration Date 11/20/2026 | 219 | ||||||
| 62,749 | Paysafe, Ltd., Strike Price $138.00, Expiration Date 12/31/2028 | 35 | ||||||
| Total Rights and Warrants | ||||||||
| (Cost $211,219) | 975 | |||||||
| SHORT TERM INVESTMENTS: 1.94% | ||||||||
| 925,469 | First American Government Obligations Fund, Class X 3.612% (b) | 925,469 | ||||||
| Total Short Term Investments | ||||||||
| (Cost $925,469) | 925,469 | |||||||
| Total Investments: 99.84% | ||||||||
| (Cost $34,545,121) | 47,649,758 | |||||||
| Other Assets In Excess Of Liabilities: 0.16% | 75,551 | |||||||
| Net Assets: 100.00% | $ | 47,725,309 | ||||||
| (a) | Non-income producing security. |
| (b) | Represents the 7-day yield. |
For Fund compliance purposes, the Fund's industry classifications refer to any one or more of the industry sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by Fund management. This definition may not apply for purposes of this report, which may combine industry sub-classifications for reporting ease. Industries are shown as a percentage of net assets.
See Notes to Quarterly Schedule of Investments.
| Emerald Funds | Notes to Quarterly Schedule of Investments |
January 31, 2026 (Unaudited)
1. ORGANIZATION
Financial Investors Trust (the “Trust”), a Delaware statutory trust, is an open-end management investment company registered under the Investment
Company Act of 1940, as amended (the “1940 Act”). The Trust consists of multiple separate portfolios or series. This quarterly report describes the Emerald Growth Fund, and Emerald Finance & Banking Innovation Fund (formerly known as "Emerald Banking and Finance Fund") (each a “Fund” and collectively, the “Funds”).
The Emerald Growth Fund seeks to achieve long-term growth through capital appreciation. The Emerald Finance & Banking Innovation Fund seeks to achieve long-term growth through capital appreciation with income as a secondary objective.
2. SIGNIFICANT ACCOUNTING POLICIES
The accompanying Consolidated Schedule of Investments were prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The preparation of Schedule of Investments in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the Quarterly Schedule of Investments. Actual results could differ from those estimates. The Funds are considered an investment company for financial reporting purposes under U.S. GAAP and follows the accounting and reporting guidance applicable to investment companies in the Financial Accounting Standards Board Accounting Standards Codification Topic 946. The following is a summary of significant accounting policies consistently followed by the Funds in preparation of their Schedule of Investments.
Investment Valuation: The Funds generally value their securities based on market prices determined at the close of regular trading on the New York Stock Exchange (“NYSE”), normally, 4:00 p.m. Eastern Time, on each business day the NYSE is open for trading.
For equity securities and mutual funds that are traded on an exchange, the market price is usually the closing sale or official closing price on that exchange. In the case of equity securities not traded on an exchange, or if such closing prices are not otherwise available, the securities are valued at the mean of the most recent bid and ask prices on such day. Redeemable securities issued by open-end registered investment companies are valued at the investment company’s applicable net asset value, with the exception of exchange-traded open-end investment companies, which are priced as equity securities.
The market price for debt obligations is generally the price supplied by an independent third-party pricing service, which may use a matrix, formula or other objective method that takes into consideration quotations from dealers, market transactions in comparable investments, market indices and yield curves. If vendors are unable to supply a price, or if the price supplied is deemed to be unreliable, the market price may be determined using quotations received from one or more brokers–dealers that make a market in the security.
Equity securities that are primarily traded on foreign securities exchanges are valued at the preceding closing values of such securities on their respective exchanges, except when an occurrence subsequent to the time a value was so established is likely to have changed such value. In such an event, the fair values of those securities are determined in good faith through consideration of other factors in accordance with procedures established by Emerald Mutual Fund Advisers Trust, (the “Adviser”), as the Funds’ Valuation Designee under the general supervision of the Board of Trustees of the Trust (the “Board” or the “Trustees”).
When such prices or quotations are not available, or when the Funds’ Valuation Designee, believes that they are unreliable, securities may be priced using fair value procedures established by the Adviser pursuant to Rule 2a-5 under the 1940 Act and approved by and subject to the oversight of the Board.
Fair Value Measurements: Pursuant to Rule 2a-5 under the Investment Company Act of 1940, the Board has appointed the Adviser to serve as the Valuation Designee to perform fair value determinations for investments in the Funds. When such prices or quotations are not available, or when the Valuation Designee believes that they are unreliable, securities may be priced using fair value procedures approved by the Board. The fair valuation policies and procedures have been adopted by the Board for the fair valuation of portfolio assets held by the Funds in the event that (1) market quotations for the current price of a portfolio security or asset are not readily available, or (2) available market quotations that would otherwise be used to value a portfolio security or asset in accordance with the Funds’ Pricing Procedures appear to be unreliable. The Pricing Procedures reflect certain pricing methodologies (or “logics”) that are not “readily available market quotations” and thus are viewed and treated as fair valuations. The Valuation Designee routinely meets to discuss fair valuations of portfolio securities and other instruments held by the Funds.
A three-tier hierarchy has been established to classify fair value measurements for disclosure purposes. Inputs refer broadly to the assumptions that market participants would use in pricing the asset or liability, including assumptions about risk. Inputs may be observable or unobservable. Observable inputs are inputs that reflect the assumptions market participants would use in pricing the asset or liability that are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs are inputs that reflect the reporting entity’s own assumptions about the assumptions market participants would use in pricing the asset or liability that are developed based on the best information available. Various inputs are used in determining the value of each Fund’s investments as of the reporting period end. The designated input levels are not necessarily an indication of the risk or liquidity associated with these investments.
These inputs are categorized in the following hierarchy under applicable financial accounting standards:
| Level 1 – | Unadjusted quoted prices in active markets for identical investments, unrestricted assets or liabilities that the Funds have the ability to access at the measurement date; | |
| Level 2 – | Quoted prices which are not active, quoted prices for similar assets or liabilities in active markets or inputs other than quoted prices that are observable (either directly or indirectly) for substantially the full term of the asset or liability; and | |
| Level 3 – | Significant unobservable prices or inputs (including the Funds’ own assumptions in determining the fair value of investments) where there is little or no market activity for the asset or liability at the measurement date. |
The following is a summary of each input used to value the Funds as of January 31, 2026:
| Investments in Securities at Value(a) | Level 1 - Quoted Prices | Level 2 - Other Significant Observable Inputs | Level 3 - Significant Unobservable Inputs | Total | ||||||||||||
| Emerald Growth Fund | ||||||||||||||||
| Common Stocks | $ | 1,151,565,269 | $ | – | $ | – | $ | 1,151,565,269 | ||||||||
| Mutual Fund | 71,174,327 | – | – | 71,174,327 | ||||||||||||
| Short-Term Investment | 14,144,446 | – | – | 14,144,446 | ||||||||||||
| TOTAL | $ | 1,236,884,042 | $ | – | $ | – | $ | 1,236,884,042 | ||||||||
| Investments in Securities at Value(a) | Level 1 - Quoted Prices | Level 2 - Other Significant Observable Inputs | Level 3 - Significant Unobservable Inputs | Total | ||||||||||||
| Emerald Finance & Banking Innovation Fund | ||||||||||||||||
| Common Stocks | $ | 46,723,314 | $ | – | $ | – | $ | 46,723,314 | ||||||||
| Warrants | 975 | – | – | 975 | ||||||||||||
| Short-Term Investment | 925,469 | – | – | 925,469 | ||||||||||||
| TOTAL | $ | 47,649,758 | $ | – | $ | – | $ | 47,649,758 | ||||||||
| (a) | For detailed descriptions of sector and industry, see the accompanying Schedule of Investments. |
Investment Transactions and Investment Income: Investment transactions are accounted for on the date the investments are purchased or sold (trade date). Realized gains and losses from investment transactions are reported on an identified cost basis, which is the same basis the Funds use for federal income tax purposes. Interest income, which includes accretion of discounts, is accrued and recorded as earned. Dividend income is recognized on the ex-dividend date or for certain foreign securities, as soon as information is available to the Funds. All of the realized and unrealized gains and losses and net investment income, are allocated daily to each class in proportion to its average daily net assets.
Real Estate Investment Trusts (“REITs”): The Funds may invest a portion of their assets in REITs and are subject to certain risks associated with direct investment in REITs. REITs may be affected by changes in the value of their underlying properties and by defaults by borrowers or tenants. REITs depend generally on their ability to generate cash flow to make distributions to shareowners, and certain REITs have self-liquidation provisions by which mortgages held may be paid in full and distributions of capital returns may be made at any time. In addition, the performance of a REIT may be affected by its failure to qualify for tax-free pass-through of income under the Internal Revenue Code of 1986, as amended (the “Code”), or its failure to maintain exemption from registration under the 1940 Act. A Fund’s investments in REITs may result in such Fund’s receipt of cash in excess of the REITs’ earnings. If the Fund receives such distributions all or a portion of these distributions will constitute a return of capital to such Fund. Receiving a return of capital distribution from REITs will reduce the amount of income available to be distributed to Fund shareholders. Income from REITs generally will not be eligible for treatment as qualified dividend income. As the final character of the distributions is not known until reported by the REITs on their 1099s, the Funds utilize an average of the prior year’s reallocation information as an estimate for the current year character of distributions.
| Emerald Funds | Notes to Quarterly Schedule of Investments |
January 31, 2026 (Unaudited)
3. TRANSACTIONS WITH AFFILIATES
The following investments are in companies deemed “affiliated” (as defined in Section 2(a)(3) of the 1940 Act) with the Emerald Growth Fund during the period ended January 31, 2026. The Emerald Finance & Banking Innovation Fund had no transactions with affiliates during the period ended January 31, 2026.
| Security Name | FAIR Value as of April 30, 2025 | Purchases | Sales | Change in Unrealized Gain/(Loss) | Realized Gain/(Loss) | FAIR Value as of january 31, 2026 | Share Balance as OF January 31, 2026 | Dividends | ||||||||||||||||||||||||
| F/m Emerald Life Sciences Innovation ETF | $ | 45,971,746 | $ | - | $ | – | $ | 25,202,581 | $ | – | $ | 71,174,327 | $ | 1,997,035 | $ | – | ||||||||||||||||
| Total | $ | 45,971,746 | $ | - | $ | – | $ | 25,202,581 | $ | – | $ | 71,174,327 | $ | 1,997,035 | $ | – | ||||||||||||||||